Research and Development in the Pharmaceutical Industry, October 2006 (65 pages, PDF).
“The CBO study describes the state of pharmaceutical research and development, analyzes the factors that influence drug development and examines how well markets are working to promote new treatments. In addition, the study provides information about the types of drugs that result from the industry’s research and development costs and analyzes the cost of developing new drugs. The report examines federal and private investment in new drug research and whether the industry’s “innovative performance” has declined. The study also looks at the profitability of pharmaceutical companies and how profits affect a company’s drug research and development.
Sorry, comments are closed for this post.